Analysis of renal lesions in Chinese tuberous sclerosis complex patients with different types of TSC gene mutations

Abstract We sought to explore the relationship between renal lesion features and genetic mutations in tuberous sclerosis complex (TSC) patients. TSC patients with renal lesions were subjected to TSC1/2 gene next-generation sequencing (NGS). TSC1/2 mutation types and imaging examinations were screene...

Full description

Bibliographic Details
Main Authors: Wenda Wang, Yang Zhao, Xu Wang, Zhan Wang, Yi Cai, Hanzhong Li, Yushi Zhang
Format: Article
Language:English
Published: Sociedade Brasileira de Genética 2022-05-01
Series:Genetics and Molecular Biology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572022000200104&tlng=en
_version_ 1818213501498294272
author Wenda Wang
Yang Zhao
Xu Wang
Zhan Wang
Yi Cai
Hanzhong Li
Yushi Zhang
author_facet Wenda Wang
Yang Zhao
Xu Wang
Zhan Wang
Yi Cai
Hanzhong Li
Yushi Zhang
author_sort Wenda Wang
collection DOAJ
description Abstract We sought to explore the relationship between renal lesion features and genetic mutations in tuberous sclerosis complex (TSC) patients. TSC patients with renal lesions were subjected to TSC1/2 gene next-generation sequencing (NGS). TSC1/2 mutation types and imaging examinations were screened for combined analysis of genetic and clinical features. Seventy-three probands among TSC patients with renal lesions were included. Twenty affected relatives were also included. In total, 93 patients were included. Eighty patients (86.0%) had bilateral renal angiomyolipomas (AMLs), and one had epithelioid AML. Two patients had polycystic kidney disease, one had renal cell carcinoma, and one had Wilms tumor. Among the 73 probands, four had TSC1 mutations, 53 had TSC2 mutations, and 16 had no mutations identified (NMI). There was no statistically significant difference between TSC1 mutation, TSC2 mutation and NMI group (P= 0.309), or between familial and sporadic groups (P= 0.775) when considering AML size. There was no statistically significant difference between pathogenic/likely pathogenic and benign/likely benign/NMI groups (P= 0.363) or among patients with different mutation types of TSC2 (P= 0.906). The relationship between the conditions of TSC gene mutations and the severity of renal lesions still needs more analysis. Patients with NMI, particularly those with familial disease, need more attention because the pathogenesis remains unknown.
first_indexed 2024-12-12T06:05:18Z
format Article
id doaj.art-1915aa047b4e402e95c80b286a1ab649
institution Directory Open Access Journal
issn 1678-4685
language English
last_indexed 2024-12-12T06:05:18Z
publishDate 2022-05-01
publisher Sociedade Brasileira de Genética
record_format Article
series Genetics and Molecular Biology
spelling doaj.art-1915aa047b4e402e95c80b286a1ab6492022-12-22T00:35:17ZengSociedade Brasileira de GenéticaGenetics and Molecular Biology1678-46852022-05-0145210.1590/1678-4685-gmb-2020-0387Analysis of renal lesions in Chinese tuberous sclerosis complex patients with different types of TSC gene mutationsWenda WangYang ZhaoXu WangZhan WangYi CaiHanzhong LiYushi Zhanghttps://orcid.org/0000-0002-8058-9702Abstract We sought to explore the relationship between renal lesion features and genetic mutations in tuberous sclerosis complex (TSC) patients. TSC patients with renal lesions were subjected to TSC1/2 gene next-generation sequencing (NGS). TSC1/2 mutation types and imaging examinations were screened for combined analysis of genetic and clinical features. Seventy-three probands among TSC patients with renal lesions were included. Twenty affected relatives were also included. In total, 93 patients were included. Eighty patients (86.0%) had bilateral renal angiomyolipomas (AMLs), and one had epithelioid AML. Two patients had polycystic kidney disease, one had renal cell carcinoma, and one had Wilms tumor. Among the 73 probands, four had TSC1 mutations, 53 had TSC2 mutations, and 16 had no mutations identified (NMI). There was no statistically significant difference between TSC1 mutation, TSC2 mutation and NMI group (P= 0.309), or between familial and sporadic groups (P= 0.775) when considering AML size. There was no statistically significant difference between pathogenic/likely pathogenic and benign/likely benign/NMI groups (P= 0.363) or among patients with different mutation types of TSC2 (P= 0.906). The relationship between the conditions of TSC gene mutations and the severity of renal lesions still needs more analysis. Patients with NMI, particularly those with familial disease, need more attention because the pathogenesis remains unknown.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572022000200104&tlng=enTuberous sclerosis complex (TSC)renal lesionsTSC1 mutationsTSC2 mutations
spellingShingle Wenda Wang
Yang Zhao
Xu Wang
Zhan Wang
Yi Cai
Hanzhong Li
Yushi Zhang
Analysis of renal lesions in Chinese tuberous sclerosis complex patients with different types of TSC gene mutations
Genetics and Molecular Biology
Tuberous sclerosis complex (TSC)
renal lesions
TSC1 mutations
TSC2 mutations
title Analysis of renal lesions in Chinese tuberous sclerosis complex patients with different types of TSC gene mutations
title_full Analysis of renal lesions in Chinese tuberous sclerosis complex patients with different types of TSC gene mutations
title_fullStr Analysis of renal lesions in Chinese tuberous sclerosis complex patients with different types of TSC gene mutations
title_full_unstemmed Analysis of renal lesions in Chinese tuberous sclerosis complex patients with different types of TSC gene mutations
title_short Analysis of renal lesions in Chinese tuberous sclerosis complex patients with different types of TSC gene mutations
title_sort analysis of renal lesions in chinese tuberous sclerosis complex patients with different types of tsc gene mutations
topic Tuberous sclerosis complex (TSC)
renal lesions
TSC1 mutations
TSC2 mutations
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572022000200104&tlng=en
work_keys_str_mv AT wendawang analysisofrenallesionsinchinesetuberoussclerosiscomplexpatientswithdifferenttypesoftscgenemutations
AT yangzhao analysisofrenallesionsinchinesetuberoussclerosiscomplexpatientswithdifferenttypesoftscgenemutations
AT xuwang analysisofrenallesionsinchinesetuberoussclerosiscomplexpatientswithdifferenttypesoftscgenemutations
AT zhanwang analysisofrenallesionsinchinesetuberoussclerosiscomplexpatientswithdifferenttypesoftscgenemutations
AT yicai analysisofrenallesionsinchinesetuberoussclerosiscomplexpatientswithdifferenttypesoftscgenemutations
AT hanzhongli analysisofrenallesionsinchinesetuberoussclerosiscomplexpatientswithdifferenttypesoftscgenemutations
AT yushizhang analysisofrenallesionsinchinesetuberoussclerosiscomplexpatientswithdifferenttypesoftscgenemutations